Concomitant brachiocephalic and coronary artery disease: outcome and decision analysis

Thomas J Takach1, George J Reul, J Michael Duncan

  • 1Department of Cardiovascular Surgery, Texas Heart Institute, St. Luke's Episcopal Hospital, Houston, Texas, USA.

Insights

Treating brachiocephalic and coronary artery disease together improves outcomes. Both surgical and endovascular approaches for brachiocephalic reconstruction show excellent midterm patency, supporting further evaluation.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Interventional Cardiology

Background:

  • Concomitant brachiocephalic disease in patients with coronary artery disease complicates treatment decisions.
  • Optimal management strategies for combined brachiocephalic and coronary artery disease require further investigation.

Purpose of the Study:

  • To evaluate the outcomes of concomitant brachiocephalic reconstruction and coronary artery bypass grafting.
  • To assess the efficacy of surgical versus endovascular brachiocephalic reconstruction for coronary-subclavian steal syndrome.

Main Methods:

  • Eighty patients with combined brachiocephalic and coronary artery disease were analyzed.
  • Group A (n=48) underwent simultaneous brachiocephalic reconstruction and coronary artery bypass grafting.
  • Group B (n=32) had brachiocephalic reconstruction (surgical or endovascular) after prior coronary artery bypass grafting for coronary-subclavian steal syndrome.

Main Results:

  • All patients were asymptomatic post-intervention with low operative mortality and perioperative stroke rates.
  • Ten-year actuarial freedom from adverse events was favorable, particularly for patients receiving internal mammary artery conduits.
  • Midterm follow-up demonstrated 100% brachiocephalic patency for both surgical and endovascular treatments in Group B.

Conclusions:

  • Concomitant brachiocephalic reconstruction and coronary artery bypass grafting, especially with internal mammary artery conduits, warrants further study for improved long-term survival.
  • Both surgical and endovascular brachiocephalic reconstruction techniques are effective for managing coronary-subclavian steal syndrome.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...